trending Market Intelligence /marketintelligence/en/news-insights/trending/FAgqjpb0D4iYfn_UjEOSHw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

MEI Pharma raises $51.8M from stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


MEI Pharma raises $51.8M from stock offering

MEI Pharma Inc. said it raised $51.8 million from a public offering of shares after underwriters exercised an option to buy additional stock.

The San Diego-based company closed the offering selling 32,343,750 shares at $1.60 apiece, including 4,218,750 shares as part of the underwriters' overallotment option.

MEI Pharma intends to use net proceeds to fund its clinical development programs and for general corporate purposes.

Stifel and Wells Fargo Securities were joint book-running managers for the offering.